Compounds and their use for reducing uric acid levels
US11168075B2 · kind B2 · utility
0Cited by
15References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2020 |
| Grant date | Nov 9, 2021 |
| Priority date | — |
| Expiry date | Jul 14, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bifunctional compounds that increase uric acid excretion and reduce uric acid production, and monofunctional compounds that either increase uric acid excretion or reduce uric acid production. Methods of using these compounds for reducing uric acid levels in blood or serum, for treating disorders of uric acid metabolism, and for maintaining normal uric acid levels in blood or serum are also provided. Pharmaceutical compositions comprising the bifunctional and monofunctional compounds are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.